Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Expanding the clinical indications for α(1)-antitrypsin therapy.

Lewis EC.

Mol Med. 2012 Sep 7;18:957-70. doi: 10.2119/molmed.2011.00196. Review.

PMID:
22634722
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Augmentation therapy with alpha1-antitrypsin: novel perspectives.

Sabina J, Tobias W.

Cardiovasc Hematol Disord Drug Targets. 2013 Aug;13(2):90-8. Review.

PMID:
23987997
[PubMed - indexed for MEDLINE]
3.

Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?

Abboud RT, Ford GT, Chapman KR.

Treat Respir Med. 2005;4(1):1-8. Review.

PMID:
15725045
[PubMed - indexed for MEDLINE]
4.

Alpha-1 antitrypsin augmentation therapy.

Wewers MD, Crystal RG.

COPD. 2013 Mar;10 Suppl 1:64-7. doi: 10.3109/15412555.2013.764402. Review.

PMID:
23527997
[PubMed - indexed for MEDLINE]
5.

Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.

Mordwinkin NM, Louie SG.

Expert Opin Pharmacother. 2007 Oct;8(15):2609-14. Review.

PMID:
17931094
[PubMed - indexed for MEDLINE]
6.

alpha1-Antitrypsin deficiency: best clinical practice.

Kalsheker NA.

J Clin Pathol. 2009 Oct;62(10):865-9. doi: 10.1136/jcp.2008.063495.

PMID:
19783716
[PubMed - indexed for MEDLINE]
7.

Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.

Tirado-Conde G, Lara B, Miravitlles M.

Ther Adv Respir Dis. 2008 Feb;2(1):13-21. doi: 10.1177/1753465807088159. Review.

PMID:
19124355
[PubMed - indexed for MEDLINE]
8.

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.

Jonigk D, Al-Omari M, Maegel L, Müller M, Izykowski N, Hong J, Hong K, Kim SH, Dorsch M, Mahadeva R, Laenger F, Kreipe H, Braun A, Shahaf G, Lewis EC, Welte T, Dinarello CA, Janciauskiene S.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15007-12. doi: 10.1073/pnas.1309648110. Epub 2013 Aug 23.

PMID:
23975926
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).

Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA.

Am J Respir Crit Care Med. 1999 Dec;160(6):1968-75.

PMID:
10588615
[PubMed - indexed for MEDLINE]
10.

Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.

Louie SG, Sclar DA, Gill MA.

Ann Pharmacother. 2005 Nov;39(11):1861-9. Epub 2005 Oct 11. Review. Erratum in: Ann Pharmacother. 2005 Dec;39(12):2143.

PMID:
16219903
[PubMed - indexed for MEDLINE]
11.

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.

Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR.

Int J Chron Obstruct Pulmon Dis. 2012;7:687-96. doi: 10.2147/COPD.S34560. Epub 2012 Sep 28.

PMID:
23055718
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Blanco I, Lara B, de Serres F.

Orphanet J Rare Dis. 2011 Apr 12;6:14. doi: 10.1186/1750-1172-6-14. Review.

PMID:
21486454
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Augmentation therapy for alpha(1)-antitrypsin deficiency.

Juvelekian GS, Stoller JK.

Drugs. 2004;64(16):1743-56. Review.

PMID:
15301559
[PubMed - indexed for MEDLINE]
14.

Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.

[No authors listed]

Bull World Health Organ. 1997;75(5):397-415. Review.

PMID:
9447774
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.

Abboud RT, Ford GT, Chapman KR; Stnadards Committee of the Canadian Thoracic Society.

Can Respir J. 2001 Mar-Apr;8(2):81-8.

PMID:
11320399
[PubMed - indexed for MEDLINE]
16.

A review of α1-antitrypsin deficiency.

Stoller JK, Aboussouan LS.

Am J Respir Crit Care Med. 2012 Feb 1;185(3):246-59. doi: 10.1164/rccm.201108-1428CI. Epub 2011 Sep 29. Review.

PMID:
21960536
[PubMed - indexed for MEDLINE]
17.

Pathophysiology and treatment of alpha 1-antitrypsin deficiency.

MacDonald JL, Johnson CE.

Am J Health Syst Pharm. 1995 Mar 1;52(5):481-9;quiz 544-5. Review.

PMID:
7606551
[PubMed - indexed for MEDLINE]
18.

Alpha-1 antitrypsin: now available, but do we need it?

Russi EW.

Swiss Med Wkly. 2008 Apr 5;138(13-14):191-6. doi: 2008/13/smw-11991. Review.

PMID:
18389391
[PubMed - indexed for MEDLINE]
Free Article
19.

Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.

Nita I, Hollander C, Westin U, Janciauskiene SM.

Respir Res. 2005 Jan 31;6:12.

PMID:
15683545
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Alpha-1-antitrypsin and other proteinase inhibitors.

Miravitlles M.

Curr Opin Pharmacol. 2012 Jun;12(3):309-14. doi: 10.1016/j.coph.2012.02.004. Epub 2012 Feb 23. Review.

PMID:
22365503
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk